Cambridge Investment Research Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.81M | Sell |
37,992
-6,416
| -14% | -$338K | ﹤0.01% | 1671 |
|
|
2025
Q4 | $2.33M | Sell |
44,408
-2,179
| -5% | -$130K | 0.01% | 1404 |
|
|
2025
Q3 | $3.02M | Buy |
46,587
+1,120
| +2% | +$64.3K | 0.01% | 1211 |
|
|
2025
Q2 | $2.21M | Buy |
45,467
+6,278
| +16% | +$243K | 0.01% | 1361 |
|
|
2025
Q1 | $1.33M | Buy |
39,189
+4,914
| +14% | +$208K | ﹤0.01% | 1640 |
|
|
2024
Q4 | $1.35M | Buy |
34,275
+9,973
| +41% | +$471K | ﹤0.01% | 1638 |
|
|
2024
Q3 | $1.14M | Sell |
24,302
-4,238
| -15% | -$215K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $1.54M | Sell |
28,540
-27,797
| -49% | -$1.61M | 0.01% | 1468 |
|
|
2024
Q1 | $3.84M | Buy |
56,337
+8,408
| +18% | +$602K | 0.01% | 897 |
|
|
2023
Q4 | $3M | Buy |
47,929
+24,839
| +108% | +$1.37M | 0.01% | 969 |
|
|
2023
Q3 | $1.05M | Sell |
23,090
-2,040
| -8% | -$105K | ﹤0.01% | 1543 |
|
|
2023
Q2 | $1.41M | Sell |
25,130
-712
| -3% | -$40.4K | 0.01% | 1380 |
|
|
2023
Q1 | $1.17M | Sell |
25,842
-861
| -3% | -$41.8K | 0.01% | 1474 |
|
|
2022
Q4 | $1.08M | Buy |
26,703
+710
| +3% | +$37.7K | 0.01% | 1472 |
|
|
2022
Q3 | $1.7M | Sell |
25,993
-1,545
| -6% | -$112K | 0.01% | 1125 |
|
|
2022
Q2 | $1.67M | Buy |
27,538
+5,708
| +26% | +$336K | 0.01% | 1133 |
|
|
2022
Q1 | $1.37M | Buy |
21,830
+4,801
| +28% | +$301K | 0.01% | 1371 |
|
|
2021
Q4 | $1.29M | Sell |
17,029
-5,077
| -23% | -$444K | 0.01% | 1416 |
|
|
2021
Q3 | $2.47M | Sell |
22,106
-5,382
| -20% | -$676K | 0.01% | 980 |
|
|
2021
Q2 | $4.45M | Buy |
27,488
+7,726
| +39% | +$940K | 0.02% | 680 |
|
|
2021
Q1 | $2.41M | Buy |
19,762
+2,015
| +11% | +$304K | 0.01% | 922 |
|
|
2020
Q4 | $2.72M | Buy |
17,747
+6,690
| +61% | +$791K | 0.02% | 768 |
|
|
2020
Q3 | $925K | Buy |
11,057
+4,656
| +73% | +$413K | 0.01% | 1234 |
|
|
2020
Q2 | $470K | Buy |
6,401
+498
| +8% | +$29.1K | ﹤0.01% | 1591 |
|
|
2020
Q1 | $250K | Sell |
5,903
-995
| -14% | -$51.4K | ﹤0.01% | 1784 |
|
|
2019
Q4 | $420K | Sell |
6,898
-5,984
| -46% | -$327K | ﹤0.01% | 1689 |
|
|
2019
Q3 | $528K | Sell |
12,882
-18,181
| -59% | -$869K | ﹤0.01% | 1463 |
|
|
2019
Q2 | $1.46M | Buy |
+31,063
| New | +$1.24M | 0.01% | 839 |
|
|
2018
Q4 | – | Sell |
-7,670
| Closed | -$340K | – | 2178 |
|
|
2018
Q3 | $340K | Buy |
+7,670
| New | +$402K | ﹤0.01% | 1716 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
